Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
PHASE3CompletedINTERVENTIONAL
Enrollment
54
Participants
Timeline
Start Date
June 30, 2003
Study Completion Date
February 28, 2005
Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DRUG
Tegaserod
Trial Locations (2)
70001
Drug Research Services, Inc, Metairie
73104
The Oklahoma Foundation for Digestive Research, Oklahoma City
NCT00171418 - Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). | Biotech Hunter | Biotech Hunter